ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

ClinicalTrials.gov ID: NCT03307980

Public ClinicalTrials.gov record NCT03307980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A FACTOR IX (FIX) GENE TRANSFER, MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B

Study identification

NCT ID
NCT03307980
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
21 participants

Conditions and interventions

Conditions

Interventions

  • PF-06838435 (formerly SPK-9001) Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2017
Primary completion
May 28, 2029
Completion
Oct 24, 2029
Last update posted
May 4, 2026

2017 – 2029

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
UC Davis Ellison Ambulatory Care Clinic Sacramento California 95817
UC Davis Medical Center department of Radiology Sacramento California 95817
UC Davis Medical Center Sacramento California 95817
UC DavisHealth Main Hospital Sacramento California 95817
University Medical Center New Orleans New Orleans Louisiana 70112
Mississippi Center for Advanced Medicine Madison Mississippi 39110
Weill Cornell Medicine - New York Presbyterian Hospital New York New York 10065
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03307980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03307980 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →